BioTel Research Blog


Progress in Immune-Oncology Imaging

The advent of immune checkpoint inhibition and other immune-related therapies has produced a sea change in the treatment of a wide range of oncology indications. The impact of these new treatment [...]

April 22, 2019


Global NASH Congress 2019

As an attendee at the recent Global Nonalcoholic Steatohepatitis (NASH) Congress in London, England, I was among a good mix of academics and industry. Much of the conference focused on noninvasive [...]

March 15, 2019


Response Assessment in Immune-Oncology

Seven years after the approval of the first immune checkpoint inhibitor for the treatment of metastatic melanoma, immunotherapy remains one of the primary areas of focus for oncology drug [...]

March 13, 2018



Ironically, the 2018 NASH-TAG conference in the Rocky Mountains featured much less snow than we have “enjoyed” in the northeast this winter. Weather forced one speaker to present remotely from his [...]

February 15, 2018


Archived Webinar: Body Composition in Clinical Trials – From BMI to MRI

According to the WHO, obesity is an epidemic that kills at least 2.8 million people each year.  The number of obese children and adolescents worldwide has risen tenfold in the past four decades. [...]

January 16, 2018


Archived Webinar: Optimize the Imaging in Clinical Trials by Aligning Operational Excellence and Scientific Expertise

The purpose of most clinical trials really boils down to a single question: Does my drug work? If you're feeling really ambitious, you may add a second question: How does my drug work? Medical [...]

August 02, 2017

BioTel Research, One Preserve Parkway, Suite #600, Rockville, MD 20852